AKT1 and non-small cell lung carcinoma: The results indicated that high expression of G3BP1 was proved to be a poor prognostic factor for NSCLC patients (P = .039), as well as pathological degree (P = .002) and clinical stage (P = .036). Nevertheless, increased expression of p‐AKT and YB1 had no significant impact on prognosis of NSCLC patients.